Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination-specific humoral and cellular immunity in kidney transplant recipients.
Schrezenmeier E, Rincon-Arevalo H, Jens A, Stefanski AL, Hammett C, Osmanodja B, Koch N, Zukunft B, Beck J, Oellerich M, Proß V, Stahl C, Choi M, Bachmann F, Liefeldt L, Glander P, Schütz E, Bornemann-Kolatzki K, López Del Moral C, Schrezenmeier H, Ludwig C, Jahrsdörfer B, Eckardt KU, Lachmann N, Kotsch K, Dörner T, Halleck F, Sattler A, Budde K. Schrezenmeier E, et al. Among authors: zukunft b. JCI Insight. 2022 May 9;7(9):e157836. doi: 10.1172/jci.insight.157836. JCI Insight. 2022. PMID: 35349490 Free PMC article.
A multicenter, matched case-control analysis comparing burden of illness among patients with tuberous sclerosis complex related epilepsy, generalized idiopathic epilepsy, and focal epilepsy in Germany.
Lappe L, Hertzberg C, Knake S, Knuf M, von Podewils F, Willems LM, Kovac S, Zöllner JP, Sauter M, Kurlemann G, Mayer T, Bertsche A, Marquard K, Meyer S, Schäfer H, Thiels C, Zukunft B, Schubert-Bast S, Reese JP, Rosenow F, Strzelczyk A. Lappe L, et al. Among authors: zukunft b. Neurol Res Pract. 2024 May 30;6(1):29. doi: 10.1186/s42466-024-00323-6. Neurol Res Pract. 2024. PMID: 38812055 Free PMC article.
Donor-specific HLA antibodies in a cohort comparing everolimus with cyclosporine after kidney transplantation.
Liefeldt L, Brakemeier S, Glander P, Waiser J, Lachmann N, Schönemann C, Zukunft B, Illigens P, Schmidt D, Wu K, Rudolph B, Neumayer HH, Budde K. Liefeldt L, et al. Among authors: zukunft b. Am J Transplant. 2012 May;12(5):1192-8. doi: 10.1111/j.1600-6143.2011.03961.x. Epub 2012 Feb 2. Am J Transplant. 2012. PMID: 22300538 Free article. Clinical Trial.
Everolimus in de novo kidney transplant recipients participating in the Eurotransplant senior program: Results of a prospective randomized multicenter study (SENATOR).
Brakemeier S, Arns W, Lehner F, Witzke O, Vonend O, Sommerer C, Mühlfeld A, Rath T, Schuhmann R, Zukunft B, Kroeger I, Porstner M, Budde K. Brakemeier S, et al. Among authors: zukunft b. PLoS One. 2019 Sep 19;14(9):e0222730. doi: 10.1371/journal.pone.0222730. eCollection 2019. PLoS One. 2019. PMID: 31536556 Free PMC article. Clinical Trial.
eHealth in transplantation.
Duettmann W, Naik MG, Zukunft B, Osmonodja B, Bachmann F, Choi M, Roller R, Mayrdorfer M, Halleck F, Schmidt D, Budde K. Duettmann W, et al. Among authors: zukunft b. Transpl Int. 2021 Jan;34(1):16-26. doi: 10.1111/tri.13778. Epub 2020 Nov 27. Transpl Int. 2021. PMID: 33111393 Free article. Review.
27 results